Related Experiment Videos
Monoclonal antibodies and glioma
Progress in Experimental Tumor Research
|January 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
COX2 Effects on endometrial carcinomas progression.
Pathology, research and practice·2022
GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19.
Research square·2022
How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.
Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Heavy metals effect on breast cancer progression.
Journal of occupational medicine and toxicology (London, England)·2017
Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature.
Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Quantitative Evaluation of Medial Temporal Lobe Morphology in Children with Febrile Status Epilepticus: Results of the FEBSTAT Study.
AJNR. American journal of neuroradiology·2016
The neuro-neoplastic synapse: does it exist?
Progress in experimental tumor research·2007
Potential inhibition of the neuro-neoplastic interactions: the clue of a GPCR-targeted therapy.
Progress in experimental tumor research·2007
Stem cells and neurogenesis in tumors.
Progress in experimental tumor research·2007
Neurotransmitter effects on tumor cells and leukocytes.
Progress in experimental tumor research·2007
Neoneurogenesis and the neuro-neoplastic synapse.
Progress in experimental tumor research·2007
Chemotropic axon guidance molecules in tumorigenesis.
Progress in experimental tumor research·2007
Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.
JTO clinical and research reports·2026
Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
B-cells in breast cancer: current insights and challenges.
Frontiers in oncology·2026
The heterogeneous and dynamic immune-tumor interface in breast cancer.
Frontiers in oncology·2026